Showing results (1681-1690 of 1,988) with videos related to

Sort By:
Pageof 199
Annals of Neurology|November 22, 2024
Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-Age AdultsNatasha A Choudhury, Shreya Mukherjee, Tracey Singer, et al.
Annals of Clinical and Translational Neurology|October 22, 2019
Impaired cognition predicts the risk of hospitalization and death in cirrhosisMinjee Kim, Eric M Liotta, Phyllis C Zee, et al.
Proteomics|November 5, 2003
Signal pathway profiling of prostate cancer using reverse phase protein arraysRobert L Grubb, Valerie S Calvert, Julia D Wulkuhle, et al.
Journal of Drug Targeting|March 28, 2008
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIaMamoru Shoji, Aiming Sun, Walter Kisiel, et al.
Brain Communications|January 8, 2025
Vaccination prior to SARS-CoV-2 infection does not affect the neurologic manifestations of long COVIDShreya Mukherjee, Tracey Singer, Aditi Venkatesh, et al.
Molecular & Cellular Proteomics : MCP|August 1, 2008
A portrait of tissue phosphoprotein stability in the clinical tissue procurement processVirginia Espina, Kirsten H Edmiston, Michael Heiby, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVIDLavanya Visvabharathy, Barbara A Hanson, Zachary S Orban, et al.
Plos Neglected Tropical Diseases|June 16, 2025
Mass spectrometry-based discovery and diagnostic validation of T. cruzi antigens in the urine of congenitally infected Chagas Disease patientsKathryn Cassels, Raghad Almofeez, Jessica Roman, et al.
Frontiers in Immunology|September 11, 2023
Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid proteinLavanya Visvabharathy, Barbara A Hanson, Zachary S Orban, et al.
Cell Reports Methods|March 1, 2022
Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugsBrian Hetrick, Linda D Chilin, Sijia He, et al.
Pageof 199